Navigation Links
Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
Date:5/18/2009

nts taking Zyprexa should be monitored regularly for worsening of glucose control. Patients starting treatment with Zyprexa should undergo fasting blood glucose testing at the beginning of treatment and periodically during treatment. Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, palyphagia and weakness. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing.

Undesirable alterations in lipids have been observed with Zyprexa use. Clinical monitoring, including baseline and follow-up lipid evaluations in patients using Zyprexa, is advised. Significant, and sometimes very high, elevations in triglyceride levels and modest mean elevations in total cholesterol have been observed with Zyprexa use.

Potential consequences of weight gain should be considered prior to starting Zyprexa. Patients receiving Zyprexa should receive regular monitoring of weight.

As with all antipsychotic treatment, prescribing should be consistent with the need to minimize Tardive Dyskinesia (TD). The risk of developing TD and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic increase. The syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn.

Zyprexa may induce orthostatic hypotension associated with dizziness, tachycardia, bradycardia, and in some patients, syncope, especially during the initial dose-titration period. Particular caution should be used in patients with known cardiovascular disease, cerebrovascular diseases, or those predisposed to hypotension.

Other potentially serious adverse events include seizures, elevated prolactin levels, elevated liver enzymes, cognitive and motor impairment, body temperature elevation and trouble swallowing
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Researchers Create Long-Acting Local Anesthetic
2. Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven
3. US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value
4. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
5. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
6. Studies Ignite Hope for Long-Acting Allergy Vaccines
7. FDA Issues Not-Approvable Letter for Lillys Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
8. Testosterone Injections Offer Hope for Male Contraceptive
9. Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
10. Consumer Alert: Illegal Silicone Injections Result in Death
11. Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and ... hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, ...
(Date:9/1/2015)... Burlington, MA (PRWEB) , ... September 01, 2015 ... ... for remote real-time monitoring and analysis of pet vital signs and activity, today ... Cornerstone is one of the most popular and widely-adopted veterinary hospital Practice Management ...
(Date:9/1/2015)... ME (PRWEB) , ... September 01, 2015 , ... Royal ... large, new study that followed men and women for 19 years and found that, ... who did not take multivitamins. , The report is part of the September 2015 ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most respected ... food and dining. , Recently named “the next big thing” in the culinary ... for telling the whole story behind food and reclaiming culinary traditions on the brink ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER TOLEDO is pleased to ... the Connectivity Kit, EasySampler data is automatically transferred to, and reported with, the ... touchscreen platform. , EasySampler fully automates the sampling process including sampling ...
Breaking Medicine News(10 mins):Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3
... named,Richard L. Wonsettler to the newly created position of ... Wonsettler, who has nearly 20 years of financial,management experience ... that Cohera Medical is preparing to enter the clinical ... "We are entering an important phase in the ...
... 30 /PRNewswire-FirstCall/ - SXC Health Solutions Corp.,("SXC" or ... a leading provider of,technology and pharmacy benefits management ... for its informedRx(R) pharmacy benefit management,("PBM") services with ... begin providing its services for more than 6,000 ...
... Response by End of Week -, LAVAL, ... DDS;,NASDAQ: DDSS) today announced that the Company has ... Administration (FDA) regarding its most recent,appeal of the ... once-daily,tramadol formulation through the Formal Dispute Resolution process., ...
... national investigation of the drug called Diditek. In April ... UDL Laboratories Digitek (digoxin tablets, USP, all strengths) for ... time many consumers or their families have received notification ... to talk to any consumer who took this drug ...
... new assistive technology developed by engineers at the ... severe disabilities lead more independent lives. , ... operate a computer, control a powered wheelchair and ... tongues. , "This device could revolutionize the field ...
... are twice as likely to develop rheumatoid arthritis in ... ahead of print in the Annals of the ... origin of disease theory, which argues that certain conditions ... during the pregnancy. , Diabetes, coronary heart disease, and ...
Cached Medicine News:Health News:Cohera Medical Names Richard L. Wonsettler as Company's First CFO 2Health News:The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services 2Health News:The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services 3Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 2Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 3Health News:US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims 2Health News:US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims 3Health News:Tongue Drive system lets persons with disabilities operate powered wheelchairs, computers 2Health News:Tongue Drive system lets persons with disabilities operate powered wheelchairs, computers 3Health News:Tongue Drive system lets persons with disabilities operate powered wheelchairs, computers 4
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, 2015, ... Oregon denied motions to dismiss securities ... GALE ) and certain of its directors. The class ... "pump and dump" scheme to artificially inflate Galena,s stock ... the stock price was inflated, sold massive amounts of ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... Mich., Oct. 19 Stryker Corporation (NYSE: SYK ... 2010 as follows: Third Quarter Highlights ... currency basis (6.9% as reported) to $1,768 million Orthopaedic ... as reported) MedSurg Equipment sales increased 16.3% on ...
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: